![](/public/assets/GP-and-patient-515829216.jpg)
Update on bowel cancer screening during COVID-19
27 April 2020
The National Bowel Cancer Screening Program is encouraging healthcare providers to continue to recommend routine screening to eligible patients during the COVID-19 pandemic.
The cancerscreening.gov.au website has been updated to ensure providers have guidance about managing screening and followup during this time.
- the National Cancer Screening Register and contact centre will remain operational. Participants will continue to receive screening kits and results through the mail
- people with positive iFOBT results will still require follow-up, and their results letter will tell them to contact their GP to seek advice
- when a GP or practice receives a positive iFOBT result for a participant, they may contact the participant to initiate a consult either via telehealth or face to face, and follow up patients who fail to attend. GPs should continue to refer patients to colonoscopy services for further investigation where appropriate
- due to the unprecedented pressure on the Australian health system, it is expected there may be some disruptions and delays for follow-up appointments and/or procedures for participants who receive positive results
- colonoscopy specialists will prioritise patients as appropriate
- evidence suggests that a short delay in colonoscopy after a positive iFOBT result will not worsen the prognosis.